Recent

% | $
Quotes you view appear here for quick access.

Seattle Genetics, Inc. Message Board

fib1_1_2_3_5 2 posts  |  Last Activity: Jun 4, 2015 10:38 AM Member since: Dec 8, 2000
  • Reply to

    Any update from Jeffries?

    by cjdbs Jun 3, 2015 4:37 PM
    fib1_1_2_3_5 fib1_1_2_3_5 Jun 4, 2015 10:38 AM Flag

    Still saying Q3 for the data from the 2nd P2 for TRV130, but clinical trials .gov says Jun so hopefully it will be within 1-2 months.

    I would suspect late Q3 or Q4 we would hear word on the P3 trial plans for 130 (still saying they hope to start on Q1 '16, but would be nice to hear some more details).

    The heart failure drug (027) is looking at Q1 '16 for data. This one has a go-nogo by their partner which could provide a milestone payment.

    And that is about it for anything that can actually move the stock.

  • Reply to

    V-Pack sale was $230 million

    by boja4 Apr 23, 2015 3:18 PM
    fib1_1_2_3_5 fib1_1_2_3_5 Apr 23, 2015 5:21 PM Flag

    Only about $10M ( and that is next Q).

    But that's a start. Should be at $40M/Q or so by EOY. Add that to cash in hand of about $200M and things are OK by me.

SGEN
48.01+0.36(+0.76%)11:10 AMEDT